Molecular Pathogenesis of Myocarditis and Cardiomyopathy: Analysis of Virus-Receptor Interactions and Tyrosine Phosphorylation Events

[1]  B. McManus,et al.  Enterovirus-infected immune cells of spleen and lymph nodes in the murine model of chronic myocarditis: a role in pathogenesis? , 1995, European heart journal.

[2]  P. Hofschneider,et al.  Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses , 1995, Journal of virology.

[3]  R. Bates,et al.  Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment , 1995, Journal of virology.

[4]  K. Korn,et al.  Nested PCR for specific detection and rapid identification of human picornaviruses , 1994, Journal of clinical microbiology.

[5]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[6]  D. Bowers,et al.  What lessons can be learned from animal model studies in viral heart disease? , 1993, Scandinavian journal of infectious diseases. Supplementum.

[7]  K. Klingel,et al.  Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. , 1993, Intervirology.

[8]  U. Walter,et al.  HIV-1 gp120 receptor on CD4-negative brain cells activates a tyrosine kinase. , 1992, Virology.

[9]  P. Hofschneider,et al.  Synergistic Interaction of Interferon-β and Interferon-γ in Coxsackievirus B3-Infected Carrier Cultures of Human Myocardial Fibroblasts , 1992 .

[10]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Chapman,et al.  Molecular biology and pathogenesis of coxsackie B viruses , 1991 .

[12]  B. McManus,et al.  Evolving concepts of cause, consequence, and control in myocarditis , 1991 .

[13]  C. Pomeroy,et al.  Latent murine cytomegalovirus DNA in splenic stromal cells of mice , 1991, Journal of virology.

[14]  P. Hofschneider,et al.  Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. , 1991, Molecular and cellular probes.

[15]  P. McLaughlin,et al.  Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. , 1990, Circulation.

[16]  B. McManus,et al.  A molecular and serologic evaluation of enteroviral involvement in human myocarditis. , 1990, Journal of molecular and cellular cardiology.

[17]  R. Kandolf,et al.  Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis , 1990, Journal of virology.

[18]  R. Kandolf.  The Impact of Recombinant DNA Technology on the Study of Enterovirus Heart Disease , 1988 .

[19]  P. Hofschneider,et al.  Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. , 1988, DNA.

[20]  P. Hofschneider,et al.  Enteroviral Heart Disease: Diagnosis by In Situ Hybridization , 1988 .

[21]  M. Bendinelli,et al.  Coxsackieviruses : a general update , 1988 .

[22]  B. McManus,et al.  Immunopathologic basis of myocardial injury. , 1988, Cardiovascular clinics.

[23]  H. Schultheiss.  New Concepts in Viral Heart Disease , 1988, Springer Berlin Heidelberg.

[24]  P. Hofschneider,et al.  In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Capobianchi,et al.  Group B coxsackieviruses readily establish persistent infections in human lymphoid cell lines , 1985, Journal of virology.

[26]  J. Mapoles,et al.  Purification of a HeLa cell receptor protein for group B coxsackieviruses , 1985, Journal of virology.

[27]  P. Hofschneider,et al.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Hofschneider,et al.  Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. , 1985, Journal of molecular and cellular cardiology.

[29]  S. Huber,et al.  Sex-related differences in the rapid production of cytotoxic spleen cells active against uninfected myofibers during Coxsackievirus B-3 infection. , 1981, Journal of immunology.

[30]  L. Philipson,et al.  Unrelated animal viruses share receptors , 1976, Nature.

[31]  L. Philipson,et al.  Specific Alterations of Coxsackievirus B3 Eluted from Hela Cells , 1971, Journal of virology.